In the last trading session, 1.83 million CERo Therapeutics Holdings Inc (NASDAQ:CERO) shares changed hands as the company’s beta touched 0.54. With the company’s per share price at $0.89 changed hands at -$0.22 or -19.81% during last session, the market valuation stood at $4.98M. CERO’s last price was a discount, traded about -19113.48% off its 52-week high of $171.00. The share price had its 52-week low at $0.53, which suggests the last value was 40.45% up since then. When we look at CERo Therapeutics Holdings Inc’s average trading volume, we note the 10-day average is 7.75 million shares, with the 3-month average coming to 1.83 million.
CERo Therapeutics Holdings Inc (NASDAQ:CERO) trade information
Instantly CERO was in red as seen at the end of in last trading. With action 44.26%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -85.16%, with the 5-day performance at 44.26% in the green. However, in the 30-day time frame, CERo Therapeutics Holdings Inc (NASDAQ:CERO) is 5.29% up. Looking at the short shares, we see there were 0.31 million shares sold at short interest cover period of 0.35 days.
The 2025 estimates are for CERo Therapeutics Holdings Inc earnings to increase by 59.83%, but the outlook for the next 5-year period is at 62.86% per year.
CERO Dividends
CERo Therapeutics Holdings Inc is expected to release its next quarterly earnings report in May.
CERo Therapeutics Holdings Inc (NASDAQ:CERO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 15.30% of CERo Therapeutics Holdings Inc shares while 6.34% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.48%.
Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . With 4.92 shares estimated at $4383.0 under it, the former controlled 0.09% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.02% of the shares, roughly 1.12 shares worth around $996.0.
